表紙
市場調査レポート

英国における培養皮膚(代用皮膚)市場の見通し

United Kingdom Tissue Engineered - Skin Substitutes Market Outlook to 2020

発行 GlobalData 商品コード 316783
出版日 ページ情報 英文 46 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.75円で換算しております。
Back to Top
英国における培養皮膚(代用皮膚)市場の見通し United Kingdom Tissue Engineered - Skin Substitutes Market Outlook to 2020
出版日: 2014年10月15日 ページ情報: 英文 46 Pages
概要

当レポートでは、英国における培養皮膚(代用皮膚)市場について調査分析し、市場セグメント別の市場規模データ、年間の市場収益・数量・平均販売価格、企業シェア・流通シェアデータ、主要企業プロファイルなどについて、体系的な情報を提供しています。

第1章 目次

第2章 イントロダクション

第3章 英国における培養皮膚(代用皮膚)市場

  • 培養皮膚(代用皮膚)市場、英国、収益実績($m)
  • 培養皮膚(代用皮膚)市場、英国、収益予測($m)
    • 生物学的代用皮膚市場、英国、収益実績($m)、セグメント別
    • 生物学的代用皮膚市場、英国、収益予測($m)、セグメント別
  • 培養皮膚(代用皮膚)市場、英国、数量実績
  • 培養皮膚(代用皮膚)市場、英国、数量予測
    • 生物学的代用皮膚市場、英国、数量実績、セグメント別
    • 生物学的代用皮膚市場、英国、数量予測、セグメント別
  • 培養皮膚(代用皮膚)市場、英国、平均販売価格($)
  • 培養皮膚(代用皮膚)市場、英国、収益別の流通シェア($m)
  • 培養皮膚(代用皮膚)市場、英国、収益別の企業シェア($m)

第4章 英国における主要企業の概要、培養皮膚(代用皮膚)市場

  • Organogenesis, Inc.
  • Smith & Nephew Plc
  • Molnlycke Health Care AB
  • BSN medical GmbH
  • Covidien plc

第5章 付録

目次
Product Code: GDMECC0860DB

GlobalData's new report, "United Kingdom Tissue Engineered - Skin Substitutes Market Outlook to 2020", provides key market data on the United Kingdom Tissue Engineered - Skin Substitutes market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Synthetic Skin Substitutes, Biosynthetic Skin Substitutes and Biologic Skin Substitutes (Allograft (Cellular and Acellular) and Xenograft Acellular).

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Tissue Engineered - Skin Substitutes market wherever available.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size data for Tissue Engineered - Skin Substitutes market segments - Synthetic Skin Substitutes, Biosynthetic Skin Substitutes and Biologic Skin Substitutes.
  • Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020.
  • 2013 company shares and distribution shares data for Tissue Engineered - Skin Substitutes market.
  • Global corporate-level profiles of key companies operating within the United Kingdom Tissue Engineered - Skin Substitutes.
  • Key players covered include Organogenesis, Inc., Smith & Nephew Plc and Molnlycke Health Care AB.

Reasons to buy

  • Develop business strategies by identifying the key market categories and segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About
  • 2.2. Tissue Engineered - Skin Substitutes Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Tissue Engineered - Skin Substitutes Market, United Kingdom

  • 3.1. Tissue Engineered - Skin Substitutes Market, United Kingdom, Revenue ($m), 2005-2013
  • 3.2. Tissue Engineered - Skin Substitutes Market, United Kingdom, Revenue ($m), 2013-2020
    • 3.2.1. Biologic Skin Substitutes Market, United Kingdom, Revenue ($m), by Segment, 2005-2013
    • 3.2.2. Biologic Skin Substitutes Market, United Kingdom, Revenue ($m), by Segment, 2013-2020
  • 3.3. Tissue Engineered - Skin Substitutes Market, United Kingdom, Volume (Units), 2005-2013
  • 3.4. Tissue Engineered - Skin Substitutes Market, United Kingdom, Volume (Units), 2013-2020
    • 3.4.1. Biologic Skin Substitutes Market, United Kingdom, Volume (Units), by Segment, 2005-2013
    • 3.4.2. Biologic Skin Substitutes Market, United Kingdom, Volume (Units), by Segment, 2013-2020
  • 3.5. Tissue Engineered - Skin Substitutes Market, United Kingdom, Average Price ($), 2005-2020
  • 3.6. Tissue Engineered - Skin Substitutes Market, United Kingdom, Distribution Share by Revenue ($m), 2012-2013
  • 3.7. Tissue Engineered - Skin Substitutes Market, United Kingdom, Company Share by Revenue ($m), 2012-2013

4. Overview of Key Companies in United Kingdom, Tissue Engineered - Skin Substitutes Market

  • 4.1. Organogenesis, Inc.
    • 4.1.1. Company Overview
  • 4.2. Smith & Nephew Plc
    • 4.2.1. Company Overview
  • 4.3. Molnlycke Health Care AB
    • 4.3.1. Company Overview
  • 4.4. BSN medical GmbH
    • 4.4.1. Company Overview
  • 4.5. Covidien plc
    • 4.5.1. Company Overview

5. Appendix

  • 5.1. Research Methodology
    • 5.1.1. Coverage
    • 5.1.2. Secondary Research
    • 5.1.3. Primary Research
    • 5.1.4. Market Modeling and Forecasting
    • 5.1.5. Company Share Analysis
    • 5.1.6. Distribution Share Analysis
  • 5.2. Expert Panel
  • 5.3. GlobalData Consulting
  • 5.4. Contact Us
  • 5.5. Disclaimer

List of Tables

  • Table 1: Tissue Engineered - Skin Substitutes Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 2: Tissue Engineered - Skin Substitutes Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 3: Biologic Skin Substitutes Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 4: Allograft Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 5: Biologic Skin Substitutes Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 6: Allograft Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 7: Tissue Engineered - Skin Substitutes Market, United Kingdom, Volume (Units), Historic, 2005-2013
  • Table 8: Tissue Engineered - Skin Substitutes Market, United Kingdom, Volume (Units), Forecast, 2013-2020
  • Table 9: Biologic Skin Substitutes Market, United Kingdom, Volume (Units), Historic, 2005-2013
  • Table 10: Allograft Market, United Kingdom, Volume (Units), Historic, 2005-2013
  • Table 11: Biologic Skin Substitutes Market, United Kingdom, Volume (Units), Forecast, 2013-2020
  • Table 12: Allograft Market, United Kingdom, Volume (Units), Forecast, 2013-2020
  • Table 13: Tissue Engineered - Skin Substitutes Market, United Kingdom, Average Price ($), Historic, 2005-2013
  • Table 14: Tissue Engineered - Skin Substitutes Market, United Kingdom, Average Price ($), Forecast, 2013-2020
  • Table 15: Tissue Engineered - Skin Substitutes Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2012-2013
  • Table 16: Tissue Engineered - Skin Substitutes Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2012-2013
  • Table 17: Total Number of Primary Research Participants, Wound Care Management, by Country

List of Figures

  • Figure 1: Tissue Engineered - Skin Substitutes Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 2: Tissue Engineered - Skin Substitutes Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 3: Biologic Skin Substitutes Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 4: Allograft Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 5: Biologic Skin Substitutes Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 6: Allograft Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 7: Tissue Engineered - Skin Substitutes Market, United Kingdom, Volume (Units), Historic, 2005-2013
  • Figure 8: Tissue Engineered - Skin Substitutes Market, United Kingdom, Volume (Units), Forecast, 2013-2020
  • Figure 9: Biologic Skin Substitutes Market, United Kingdom, Volume (Units), Historic, 2005-2013
  • Figure 10: Allograft Market, United Kingdom, Volume (Units), Historic, 2005-2013
  • Figure 11: Biologic Skin Substitutes Market, United Kingdom, Volume (Units), Forecast, 2013-2020
  • Figure 12: Allograft Market, United Kingdom, Volume (Units), Forecast, 2013-2020
  • Figure 13: Tissue Engineered - Skin Substitutes Market, United Kingdom, Company Share (%), 2013
  • Figure 14: GlobalData Epidemiology-Based Forecasting Model
  • Figure 15: GlobalData Capital Equipment-Based Forecasting Model
  • Figure 16: Primary Interviews by Participant Type (%)
Back to Top